• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin

Article

Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."

Related Videos
Dr Mark Fendrick
Dr Vishnukamal Golla
Experts at the PCOC conference
Mark Riggle, PharmD
Dr Sophia Humphreys
Dr Vivek Subbiah
Katherine Koh, MD, MSc
Vivek Bhalla, MD, Stanford University School of Medicine
Dr Jeremiah Duby
Dr Scott Soefje
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.